lysergic acid diethylamide has been researched along with Heart Valve Diseases in 1 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tagen, M | 1 |
| Mantuani, D | 1 |
| van Heerden, L | 1 |
| Holstein, A | 1 |
| Klumpers, LE | 1 |
| Knowles, R | 1 |
1 review available for lysergic acid diethylamide and Heart Valve Diseases
| Article | Year |
|---|---|
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease.
Topics: Hallucinogens; Heart Valve Diseases; Humans; Lysergic Acid Diethylamide; Mescaline; N-Methyl-3,4-met | 2023 |